| Metric | FY 2025↕ | FY 2024↕ | FY 2023↕ | FY 2022↕ | FY 2021↕ | FY 2020↕ | FY 2019↕ | FY 2018↕ |
|---|---|---|---|---|---|---|---|---|
| Revenue | — | — | — | — | — | — | — | — |
| Cost of Revenue | — | — | — | — | — | — | — | — |
| Gross Profit | — | — | — | — | — | — | — | — |
| R&D Expense | — | — | — | — | — | — | — | — |
| SG&A Expense | — | — | — | — | — | — | — | — |
| Operating Income | — | — | — | — | — | — | — | — |
| Net Income | $0.2B | $0.1B | $0.1B | $-0.2B | $0.3B | $0.0B | $0.1B | $0.1B |
| EPS (Basic) | $1.31 | $0.83 | $0.46 | $-2.57 | $0.67 | $0.08 | $0.80 | — |
| EPS (Diluted) | $1.30 | $0.82 | $0.46 | $-2.57 | $0.66 | $0.08 | $0.79 | — |
| Metric | FY 2025↕ | FY 2024↕ | FY 2023↕ | FY 2022↕ | FY 2021↕ | FY 2020↕ | FY 2019↕ | FY 2018↕ |
|---|---|---|---|---|---|---|---|---|
| Total Assets | $13.0B | $11.4B | $10.8B | $9.1B | $9.1B | $6.9B | $13.6B | $12.4B |
| Current Assets | — | — | — | — | — | — | — | — |
| Cash & Equivalents | $0.2B | $0.3B | $0.3B | $0.3B | $0.3B | $0.8B | $0.1B | $0.1B |
| Total Liabilities | $11.2B | $9.6B | $8.9B | $7.1B | $6.6B | $4.4B | $10.2B | $9.0B |
| Current Liabilities | — | — | — | — | — | — | — | — |
| Stockholders' Equity | $1.8B | $1.8B | $1.9B | $2.0B | $2.5B | $2.5B | $3.4B | $3.4B |
| Metric | FY 2025↕ | FY 2024↕ | FY 2023↕ | FY 2022↕ | FY 2021↕ | FY 2020↕ | FY 2019↕ | FY 2018↕ |
|---|---|---|---|---|---|---|---|---|
| Operating Cash Flow | $0.1B | $0.2B | $0.1B | $0.4B | $0.1B | $0.0B | $0.2B | $0.1B |
| Investing Cash Flow | $-1.8B | $-0.4B | $-1.5B | $-1.1B | $-2.2B | $6.4B | $-1.1B | $-2.2B |
| Capital Expenditures | — | — | — | $0.0B | $0.0B | $0.0B | $0.0B | — |
| Financing Cash Flow | $1.5B | $0.3B | $1.4B | $0.9B | $1.6B | $-5.7B | $1.0B | $1.6B |